BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33497867)

  • 1. Inhibition of Dot1L Alleviates Fulminant Hepatitis Through Myeloid-Derived Suppressor Cells.
    Yang W; Yu H; Huang J; Miao X; Wang Q; Wang Y; Cheng Y; He S; Zhao F; Meng L; Wang B; Qian F; Ren X; Jin M; Gu Y; Zhang Y; Cai W
    Cell Mol Gastroenterol Hepatol; 2021; 12(1):81-98. PubMed ID: 33497867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tpl2 Protects Against Fulminant Hepatitis Through Mobilization of Myeloid-Derived Suppressor Cells.
    Xu J; Pei S; Wang Y; Liu J; Qian Y; Huang M; Zhang Y; Xiao Y
    Front Immunol; 2019; 10():1980. PubMed ID: 31481966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells.
    Redd PS; Ibrahim ML; Klement JD; Sharman SK; Paschall AV; Yang D; Nayak-Kapoor A; Liu K
    Cancer Res; 2017 Jun; 77(11):2834-2843. PubMed ID: 28381543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like Receptor 4 Inhibitor TAK-242 Improves Fulminant Hepatitis by Regulating Accumulation of Myeloid-Derived Suppressor Cell.
    Wang H; Li X; Dong G; Yan F; Zhang J; Shi H; Ning Z; Gao M; Cheng D; Ma Q; Wang C; Zhao M; Dai J; Li C; Li Z; Zhang H; Xiong H
    Inflammation; 2021 Apr; 44(2):671-681. PubMed ID: 33083887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic RACK1 deficiency protects against fulminant hepatitis through myeloid-derived suppressor cells.
    Liu G; Wang Q; Deng L; Huang X; Yang G; Cheng Q; Guo T; Guo L; Niu C; Yang X; Dong J; Zhang J
    Theranostics; 2022; 12(5):2248-2265. PubMed ID: 35265209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mTOR signal regulates myeloid-derived suppressor cells differentiation and immunosuppressive function in acute kidney injury.
    Zhang C; Wang S; Li J; Zhang W; Zheng L; Yang C; Zhu T; Rong R
    Cell Death Dis; 2017 Mar; 8(3):e2695. PubMed ID: 28333137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Role of Inducible Nitric Oxide Synthase Expressing Myeloid-Derived Suppressor Cells in Acetaminophen-Induced Murine Liver Failure.
    Hsu CY; Lin YC; Chang LY; Huang SK; Huang CH; Yang CK; Huang CT; Lin CY
    Front Immunol; 2020; 11():574839. PubMed ID: 33250891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid-Derived Suppressor Cells in
    Fresno M; Gironès N
    Front Cell Infect Microbiol; 2021; 11():737364. PubMed ID: 34513737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SSC(high)CD11b(high)Ly-6C(high)Ly-6G(low) myeloid cells curtail CD4 T cell response by inducible nitric oxide synthase in murine hepatitis.
    Zhu K; Zhang N; Guo N; Yang J; Wang J; Yang C; Yang C; Zhu L; Xu C; Deng Q; Zhu R; Wang H; Chen X; Shi Y; Li Y; Leng Q
    Int J Biochem Cell Biol; 2014 Sep; 54():89-97. PubMed ID: 25035167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of immunosuppressive drug cyclosporine A on myeloid-derived suppressor cells in transplanted mice.
    Han C; Wu T; Na N; Zhao Y; Li W; Zhao Y
    Inflamm Res; 2016 Sep; 65(9):679-88. PubMed ID: 27147271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel α-glucan YCP improves the survival rates and symptoms in septic mice by regulating myeloid-derived suppressor cells.
    Liu D; You M; Zhao GF; Li XJ; Song YX; Dou H; Yao WB; Gao XD; Hou YY
    Acta Pharmacol Sin; 2017 Sep; 38(9):1269-1281. PubMed ID: 28649127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dexamethasone-Induced Myeloid-Derived Suppressor Cells Prolong Allo Cardiac Graft Survival through iNOS- and Glucocorticoid Receptor-Dependent Mechanism.
    Zhao Y; Shen XF; Cao K; Ding J; Kang X; Guan WX; Ding YT; Liu BR; Du JF
    Front Immunol; 2018; 9():282. PubMed ID: 29497426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The DOT1L inhibitor Pinometostat decreases the host-response against infections: Considerations about its use in human therapy.
    Marcos-Villar L; Nieto A
    Sci Rep; 2019 Nov; 9(1):16862. PubMed ID: 31727944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional characteristic of cysteine-rich protein 61: Modulation of myeloid-derived suppressor cells in liver inflammation.
    Zhang H; Lian M; Zhang J; Bian Z; Tang R; Miao Q; Peng Y; Fang J; You Z; Invernizzi P; Wang Q; Gershwin ME; Ma X
    Hepatology; 2018 Jan; 67(1):232-246. PubMed ID: 28777871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The activation of CD11b by leukadherin-1 alleviates endotoxic shock through promoting the aggregation and activation of myeloid-derived suppressor cells].
    Yao X; Dong G; Zhu Y; Yan F; Zhang H; Dai J; Li X; Xiong H; Si C
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Nov; 34(11):961-968. PubMed ID: 30591103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalein ameliorates pristane-induced lupus nephritis via activating Nrf2/HO-1 in myeloid-derived suppressor cells.
    Li D; Shi G; Wang J; Zhang D; Pan Y; Dou H; Hou Y
    Arthritis Res Ther; 2019 Apr; 21(1):105. PubMed ID: 31023362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autocrine IL6-Mediated Activation of the STAT3-DNMT Axis Silences the TNFα-RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells.
    Smith AD; Lu C; Payne D; Paschall AV; Klement JD; Redd PS; Ibrahim ML; Yang D; Han Q; Liu Z; Shi H; Hartney TJ; Nayak-Kapoor A; Liu K
    Cancer Res; 2020 Aug; 80(15):3145-3156. PubMed ID: 32554751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid-Derived Suppressor Cells Induce the Expansion of Regulatory B Cells and Ameliorate Autoimmunity in the Sanroque Mouse Model of Systemic Lupus Erythematosus.
    Park MJ; Lee SH; Kim EK; Lee EJ; Park SH; Kwok SK; Cho ML
    Arthritis Rheumatol; 2016 Nov; 68(11):2717-2727. PubMed ID: 27214349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DOT1L inhibitors block abnormal self-renewal induced by cohesin loss.
    Heimbruch KE; Fisher JB; Stelloh CT; Phillips E; Reimer MH; Wargolet AJ; Meyer AE; Pulakanti K; Viny AD; Loppnow JJ; Levine RL; Pulikkan JA; Zhu N; Rao S
    Sci Rep; 2021 Mar; 11(1):7288. PubMed ID: 33790356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.